Strata Critical Medical, Inc. (SRTA) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Strata Critical Medical, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Strata Critical Medical, Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-13.54%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Strata Critical Medical, Inc. actually do?
Answer:
Strata Critical Medical, Inc. is a time-critical logistics and medical services provider focused on the U.S. healthcare industry, specializing in organ transplant logistics and clinical services. The company operates an integrated network for donor organ recovery, offering air and ground logistics, organ placement, surgical organ recovery, and normothermic regional perfusion under its Trinity and Keystone brands. Strata aims to increase successful organ transplants by providing efficient, cost-effective solutions to transplant centers and organ procurement organizations. The company's business model leverages an asset-light approach for logistics, primarily using third-party aircraft operators, while also investing in a limited owned fleet for strategic advantages. Its clinical segment employs dedicated professionals for specialized services, often integrated with logistics for a comprehensive offering.
Question:
What are Strata Critical Medical, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by air and ground logistics services for organ transport, including flight hours, ground transportation, and revenue per trip. The clinical segment contributes revenue through surgical organ recovery, normothermic regional perfusion, preservation services, and perfusion staffing and equipment solutions.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required